HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by FEIGENSON, J. S. Articles by McDOWELL, F. H. Search for Related Content PubMed PubMed Citation Articles by FEIGENSON, J. S. Articles by McDOWELL, F. H.

Piribedil

Its synergistic effect in multidrug regimens for parkinsonism

From the Neurologic Disease and Stroke Unit of the Burke Rehabilitation Center.

Piribedil, a dopamine agonist, was administered to 13 patients with long-standing Parkinson's disease whose major symptoms were not well controlled on levodopa, anticholinergics, alpha-methyldopa, amantadine, or a combination of these agents. Twelve of the 13 clearly benefited from the addition of Piribedil although side effects precluded long term use in two cases. Beneficial results were obtained by using a combination of Piribedil, levodopa, and anticholinergic drugs. Side effects (hallucinations, confusion, dyskinesias) were frequent, but were usually reversible by lowering the dosage of levodopa or the accompanying anticholinergic medication. The synergistic effect of Piribedil and other antiparkinsonian drugs emphasizes the need for careful titration of all available medications in difficult cases and demonstrates the usefulness of dopamine receptor stimulators when drugs acting presynaptically have failed.

Requests for reprints should be addressed to Dr. Feigenson at The Burke Rehabilitation Center, White Plains, NY 10605.

This study was supported by the American Parkinson's Disease Association and a grant from Servier Laboratories.

Received for publication September 2, 1975.

This article has been cited by other articles:

				R. M. Post, R. H. Gerner, J. S. Carman, J. C. Gillin, D. C. Jimerson, F. K. Goodwin, and W. E. Bunney Jr Effects of a Dopamine Agonist Piribedil in Depressed Patients: Relationship of Pretreatment Homovanillic Acid to Antidepressant Response Arch Gen Psychiatry, May 1, 1978; 35(5): 609 - 615. [Abstract] [PDF]